Literature DB >> 223974

The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.

R Anderson, A J van Rensburg.   

Abstract

Propranolol at concentrations of 1 x 10(-6) to 1 x 10(-4) M consistently increased neutrophil motility as measured in Boyden chambers. The effects were not due solely to stimulation of random migration and chemokinesis but also of directional motility. Propranolol, over a similar concentration range, caused inhibition of post-phagocytic cell metabolic activity (hexose monophosphate shunt, nitro-blue tetrazolium reduction and protein iodination) without any detectable effect on the ingestion rate of Candida albicans. Atenolol had no effect on any of these neutrophil functions. Both drugs were without effect on glycolysis and intracellular cyclic AMP levels. Propranolol however, at concentrations which stimulated cell motility, caused increased intracellular cyclic GMP levels. It is suggested that propranolol may stimulate neutrophil motility by promoting increased intracellular cyclic GMP levels or by decreasing neutrophil superoxide production.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223974      PMCID: PMC1457311     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  ESTIMATION OF PATHWAYS OF CARBOHYDRATE METABOLISM.

Authors:  H G WOOD; J KATZ; B R LANDAU
Journal:  Biochem Z       Date:  1963

2.  Cyclic nucleotide changes in human neutrophils induced by chemoattractants and chemotactic modulators.

Authors:  G E Hatch; W K Nichols; H R Hill
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

3.  The effects of prostaglandin E1 on human granulocyte metabolism during phagocytosis.

Authors:  R H Flyer; S C Finch
Journal:  J Reticuloendothel Soc       Date:  1973-10

Review 4.  Recognition and response in mononuclear and granular phagocytes.

Authors:  P C Wilkinson
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

5.  Hormonal control of lysosomal enzyme release from human neutrophils: elevation of cyclic nucleotide levels by autonomic neurohormones.

Authors:  L J Ignarro; W J George
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

6.  Effects of levamisole on normal and abnormal leukocyte locomotion.

Authors:  D G Wright; C H Kirkpatrick; J I Gallin
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

7.  The in vitro effects of histamine and metiamide on neutrophil motility and their relationship to intracellular cyclic nucleotide levels.

Authors:  R Anderson; A Glover; A R Rabson
Journal:  J Immunol       Date:  1977-05       Impact factor: 5.422

8.  The effect of chemotactic factors and agents which influence neutrophil movement on anaerobic glycolysis and hexose monophosphate shunt activity.

Authors:  R Anderson; A Glover; A R Rabson
Journal:  Immunology       Date:  1978-07       Impact factor: 7.397

9.  The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes.

Authors:  S BOYDEN
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Hormonal control of lysosomal enzyme release from human neutrophils. Effects of autonomic agents on enzyme release, phagocytosis, and cylic nucleotide levels.

Authors:  L J Ignarro; T F Lint; W J George
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

View more
  11 in total

1.  Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.

Authors:  B M Zeis; R Anderson; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

2.  Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy.

Authors:  C E van Rensburg; E M Gatner; F M Imkamp; R Anderson
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

3.  Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.

Authors:  R Anderson; G Grabow; R Oosthuizen; A Theron; A J Van Rensburg
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

4.  Inhibition of mitogen-activated proliferation of human lymphocytes by hypochlorous acid in vitro: protection and reversal by ascorbate and cysteine.

Authors:  M J Smit; R Anderson
Journal:  Agents Actions       Date:  1990-06

5.  Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.

Authors:  B Hallengren; A Forsgren; A Melander
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

6.  Benoxaprofen: a pro-oxidant anti-inflammatory drug?

Authors:  R Anderson; P T Lukey; S P Naudé; G Jooné
Journal:  Agents Actions       Date:  1984-02

7.  Prevention of neutrophil chemotactic deactivation by ascorbic acid.

Authors:  F Patrone; F Dallegri; G Lanzi; C Sacchetti
Journal:  Br J Exp Pathol       Date:  1980-10

8.  An in vitro assessment of cellular and humoral immune function in pulmonary tuberculosis: correction of defective neutrophil motility by ascorbate, levamisole, metoprolol and propranolol.

Authors:  E M Gatner; R Anderson
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

9.  Increased leucoattractant binding and reversible inhibition of neutrophil motility mediated by the peroxidase/H2O2/halide system: effects of ascorbate, cysteine, dithiothreitol, levamisole and thiamine.

Authors:  R Anderson; P T Jones
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

10.  In vitro and in vivo stimulation of neutrophil migration and lymphocyte transformation by thiamine related to inhibition of the peroxidase/H2O2/halide system.

Authors:  A Theron; R Anderson; G Grabow; J L Meiring
Journal:  Clin Exp Immunol       Date:  1981-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.